Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease atrial fibrillation
Comorbidity C0007194|hypertrophic cardiomyopathy
Sentences 24
PubMedID- 20494669 Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 20079992 Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
PubMedID- 24280311 Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 25857916 atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors.
PubMedID- 24097220 Epicardial adipose tissue is associated with prevalent atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 21684113 Background: in addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (hcm).
PubMedID- 25452101 Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 20154076 Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24326897 Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 26493159 Background: we evaluated whether left atrial (la) phasic functions, p-wave dispersion (pwd), and plasma nt-probnp levels could predict future development of atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm).
PubMedID- 23348529 Background: atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) is generally associated with deterioration of the clinical status, functional capacity, and quality of life.
PubMedID- 24965028 atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.
PubMedID- 26302740 Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.
PubMedID- 24217781 Avoid atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 21515029 Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance.
PubMedID- 20173211 Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
PubMedID- 25814420 Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24763706 Purpose: catheter ablation of atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) is still challenging, and it is unclear whether the difficulty is caused by the hypertrophy of left atrial (la) myocardial wall thickness.
PubMedID- 25739859 Qtc interval prolongation predicts arrhythmia recurrence after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24599807 Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24014282 atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
PubMedID- 21514088 Successful electrical cardioversion in a massive concentric hypertrophic cardiomyopathy with atrial fibrillation.
PubMedID- 24114776 Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
PubMedID- 24103078 At 52 years of age, he was diagnosed with mid-ventricular obstructive hypertrophic cardiomyopathy (hcm) associated with paroxysmal atrial fibrillation.

Page: 1